T1	Pharmacological_substance 0 11	Risperidone
N1000 	Reference T1 MeSH:D018967	Risperidone
T2	Pharmacological_substance 15 30	methylphenidate
N1001 	Reference T2 MeSH:D008774	methylphenidate
T3	Pharmacological_substance 76 99	atypical antipsychotics
T4	Disorder 142 173	childhood behavioural disorders
N1 	Reference T4 UMLS:C0339005	childhood behavioural disorders
T5	Pharmacological_substance 330 345	methylphenidate
N1002 	Reference T5 MeSH:D008774	methylphenidate
T6	Pharmacological_substance 360 374	antipsychotics
N1003 	Reference T6 MeSH:D014150	antipsychotics
T7	Pharmacological_substance 379 394	methylphenidate
N1004 	Reference T7 MeSH:D008774	methylphenidate
T8	Pharmacological_substance 558 569	risperidone
N1005 	Reference T8 MeSH:D018967	risperidone
T9	Pharmacological_substance 573 588	methylphenidate
N1006 	Reference T9 MeSH:D008774	methylphenidate
T10	Disorder 645 685	attention deficit/hyperactivity disorder
N2 	Reference T10 UMLS:C1263846	attention deficit/hyperactivity disorder
T11	Disorder 687 691	ADHD
N3 	Reference T11 UMLS:C1263846	ADHD
T12	Disorder 697 726	oppositional defiant disorder
N4 	Reference T12 UMLS:C0029121	oppositional defiant disorder
T13	Disorder 754 767	hyperactivity
N5 	Reference T13 UMLS:C0424295	hyperactivity
T14	Pharmacological_substance 792 807	methylphenidate
N1007 	Reference T14 MeSH:D008774	methylphenidate
T15	Pharmacological_substance 837 848	risperidone
N1008 	Reference T15 MeSH:D018967	risperidone
T16	Pharmacological_substance 907 918	risperidone
N1009 	Reference T16 MeSH:D018967	risperidone
T17	Disorder 923 927	ADHD
N6 	Reference T17 UMLS:C1263846	ADHD
T18	Disorder 1004 1017	hyperactivity
N7 	Reference T18 UMLS:C0424295	hyperactivity
T19	Pharmacological_substance 1064 1079	methylphenidate
N1010 	Reference T19 MeSH:D008774	methylphenidate
T20	Pharmacological_substance 1275 1290	methylphenidate
N1011 	Reference T20 MeSH:D008774	methylphenidate
T21	Pharmacological_substance 1351 1366	methylphenidate
N1012 	Reference T21 MeSH:D008774	methylphenidate
T22	Pharmacological_substance 1501 1512	risperidone
N1013 	Reference T22 MeSH:D018967	risperidone
T23	Pharmacological_substance 1583 1598	methylphenidate
N1014 	Reference T23 MeSH:D008774	methylphenidate
T28	Disorder 728 731	ODD
N8 	Reference T28 UMLS:C0029121	ODD
T25	Subject 1114 1145	a 15-year-old female adolescent
T26	Subject 50 58	children
T27	Subject 473 496	three cases of children
T35	Disorder 518 535	adverse reactions
N9 	Reference T35 UMLS:C0559546	adverse reactions
T38	Subject 612 628	a 6-year-old boy
T39	Coreferring_mention 734 736	He
T40	Disorder 772 781	agitation
N10 	Reference T40 UMLS:C0085631	agitation
T44	Subject 883 894	a girl of 6
T45	Disorder 932 967	borderline intellectual functioning
N11 	Reference T45 UMLS:C0006009	borderline intellectual functioning
T47	Disorder 1033 1045	irritability
N12 	Reference T47 UMLS:C0022107	irritability
T48	Disorder 1019 1028	agitation
N13 	Reference T48 UMLS:C0085631	agitation
T49	Coreferring_mention 983 986	She
T55	Subject 1370 1382	two patients
T57	Disorder 1403 1417	adverse effect
N14 	Reference T57 UMLS:C0879626	adverse effect
T58	Negation_cue 1387 1390	not
T60	Disorder 1535 1564	altered behavioural responses
T61	Speculation_cue 1523 1526	may
T65	Disorder 1662 1679	adverse reactions
N15 	Reference T65 UMLS:C0559546	adverse reactions
